Drug
Amlenetug
Amlenetug: highest development phase Phase 3, developed by Lundbeck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Amlenetug NCT06706622 | Phase 3 | Multiple System Atrophy |
Latest
No recent events.
Follow Amlenetug on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.